Boston, Massachusetts and Singapore--(Newsfile Corp. - November 19, 2020) - AIM Biotech completed its series A financing to accelerate growth of its organ-on-a-chip business. The company's advanced research tool mimics human organs and disease models in the lab to improve, accelerate and reduce the cost of drug discovery for academic,...